logo-loader
viewBevcanna Enterprises Inc.

Full interview: Bevcanna receives Health Canada licence for Research

BevCanna (CSE: BEV) Chief Commercialization Officer Emma Andrews sat down with Proactive Vancouver’s Steve Darling with news the company has received their research licence with from Health Canada. The newly-granted license allows BevCanna to test cannabinoid infusion equipment on their bottling line, as well as in the lab.

Andrews also telling Proactive about two new lines they have debuted including Deeper Green and Gruv.

Quick facts: Bevcanna Enterprises Inc.

Price: 0.43 CAD

CSE:BEV
Market: CSE
Market Cap: $19.7 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Bevcanna Enterprises Inc. named herein, including the promotion by the Company of Bevcanna Enterprises Inc. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

BevCanna Enterprises taking advantage of CBD beverages market

Proactive Research analyst Ed Stacey says BevCanna Enterprises Inc (CNSX:BEV) is offering  investors an early-stage opportunity in the emerging market for legal cannabis products - primarily the infused beverages category. Stacey says it's a space that's anticipated to soon benefit from...

on 7/10/19

2 min read